全文获取类型
收费全文 | 6086篇 |
免费 | 12篇 |
专业分类
电工技术 | 14篇 |
化学工业 | 258篇 |
金属工艺 | 28篇 |
机械仪表 | 29篇 |
建筑科学 | 30篇 |
矿业工程 | 6篇 |
能源动力 | 16篇 |
轻工业 | 51篇 |
水利工程 | 2篇 |
石油天然气 | 7篇 |
无线电 | 129篇 |
一般工业技术 | 258篇 |
冶金工业 | 5133篇 |
原子能技术 | 16篇 |
自动化技术 | 121篇 |
出版年
2020年 | 16篇 |
2018年 | 10篇 |
2017年 | 10篇 |
2016年 | 12篇 |
2014年 | 26篇 |
2013年 | 53篇 |
2012年 | 27篇 |
2011年 | 25篇 |
2010年 | 32篇 |
2009年 | 23篇 |
2008年 | 48篇 |
2007年 | 33篇 |
2006年 | 24篇 |
2005年 | 34篇 |
2004年 | 29篇 |
2003年 | 37篇 |
2002年 | 28篇 |
2001年 | 34篇 |
2000年 | 23篇 |
1999年 | 171篇 |
1998年 | 1587篇 |
1997年 | 920篇 |
1996年 | 589篇 |
1995年 | 343篇 |
1994年 | 282篇 |
1993年 | 332篇 |
1992年 | 58篇 |
1991年 | 76篇 |
1990年 | 76篇 |
1989年 | 83篇 |
1988年 | 80篇 |
1987年 | 84篇 |
1986年 | 69篇 |
1985年 | 80篇 |
1984年 | 23篇 |
1983年 | 26篇 |
1982年 | 37篇 |
1981年 | 39篇 |
1980年 | 55篇 |
1979年 | 18篇 |
1978年 | 23篇 |
1977年 | 114篇 |
1976年 | 217篇 |
1975年 | 20篇 |
1974年 | 14篇 |
1973年 | 19篇 |
1972年 | 11篇 |
1971年 | 18篇 |
1970年 | 19篇 |
1967年 | 12篇 |
排序方式: 共有6098条查询结果,搜索用时 15 毫秒
31.
Antral washouts have been widely used in the management of chronic sinusitis. With the advent of modern antibiotics and powerful topical nasal steroids, we sought to establish if a role remains for this procedure. One hundred and fourteen patients with chronic sinusitis were randomised into two groups. Patients in Group A received antral washouts followed by antibiotics and topical nasal steroids. Patients in the Group B received antibiotics and topical nasal steroids alone. In each group 51.6 per cent and 50 per cent of patients respectively improved with treatment. The outcome of treatment is also not influenced by endoscopic abnormality. The difference was not statistically significant (p = 0.86). The study indicates that half of patients with chronic sinusitis will improve with medical treatment but the addition of antral washout confers no additional benefits. 相似文献
32.
33.
A Fassati A Bardoni M Sironi DJ Wells N Bresolin G Scarlato M Hatanaka S Yamaoka G Dickson 《Canadian Metallurgical Quarterly》1998,9(17):2459-2468
34.
35.
Prednisolone therapy of idiopathic feline lower urinary tract disease: a double-blind clinical study
CA Osborne JM Kruger JP Lulich GR Johnston DJ Polzin LK Ulrich J Sanna 《Canadian Metallurgical Quarterly》1996,26(3):563-569
A double-blind clinical study was performed to evaluate prednisolone as treatment for idiopathic feline lower urinary tract disease. No differences in response were observed in prednisolone- and placebo-treated cats. 相似文献
36.
WJ Enright DJ Prendiville LJ Spicer PR Stricker AP Moloney TF Mowles RM Campbell 《Canadian Metallurgical Quarterly》1993,71(9):2395-2405
The objective of this study was to determine the effect of long-term administration of a growth hormone (GH)-releasing factor analog (GRFa) and(or) thyrotropin-releasing hormone (TRH) on growth, feed efficiency, carcass characteristics, and blood hormones and metabolites in beef heifers. Crossbred heifers (n = 48; 345.9 +/- 2.8 kg) were divided into four equal groups: control (vehicle), 1 microgram of GRFa (human GRF 1-29 analog).kg BW-1.d-1, 1 microgram of TRH.kg BW-1.d-1, or GRFa + TRH. Daily s.c. injections continued for 86 d. Blood samples were collected from half of the heifers after injection on d 1, 36, and 78. On d 89, all heifers were slaughtered. Treatments did not affect (P > .05) ADG but GRFa + TRH decreased (P < .05) ADFI relative to all other treatments. Feed conversion efficiency tended (P < .10) to be improved in the groups given GRFa alone or TRH alone. Treatment with GRFa and(or) TRH did not affect carcass weight, dressing percentage, conformation score, backfat thickness, or weights of liver, kidneys, pituitary, and ovaries. The GRFa + TRH treatment reduced (P < .05) fat score and increased (P < .05) longissimus muscle area relative to other treatments. The GRFa treatments reduced (P < .05) the weight and fat percentage of the mammary gland and increased (P < .05) heart weight. Treatment with TRH alone failed to stimulate GH on d 1, 36, and 78. Treatment with GRFa alone increased (P < .05) GH above controls on d 36, whereas GRFa + TRH increased (P < .05) GH on d 1, 36, and 78. Treatment with GRFa alone increased (P < .05) IGF-I only on d 1, whereas GRFa + TRH was without effect on all days. Across sampling days, treatments had little effect on blood concentrations of insulin, triiodothyronine, nonesterified fatty acids, urea nitrogen, and glucose. The GRFa alone and GRFa + TRH decreased (P < .05) and TRH alone increased (P < .05) thyroxine concentrations. In conclusion, with the dose and administration regimen used, GRFa and(or) TRH yielded small but positive improvements in animal performance. 相似文献
37.
The NADPH-dependent metabolism of ifosphamide catalyzed by rat liver microsomes was investigated in order to identify individual P450 enzymes that activate this anti-cancer drug and to ascertain their relationship to the P450 enzymes that activate the isomeric drug cyclophosphamide. Pretreatment of rats with phenobarbital or clofibrate increased by up to 8-fold the activation of both ifosphamide and cyclophosphamide catalyzed by isolated liver microsomes. Studies using P450 form-selective inhibitory antibodies demonstrated that constitutively expressed P450s belonging to subfamily 2C (forms 2C11/2C6) make significant contributions to the activation of both oxazaphosphorines in uninduced male rat liver microsomes, while the phenobarbital-inducible P450 2B1 was shown to be a major catalyst of these activations in phenobarbital-induced microsomes. Pretreatment of rats with dexamethasone increased liver microsomal activation of ifosphamide approximately 6-fold without a corresponding effect on cyclophosphamide activation rates. Ifosphamide activation catalyzed by dexamethasone-induced liver microsomes was minimally inhibited by anti-P450 2B or anti-P450 2C antibodies, but was selectively inhibited by anti-P450 3A antibodies. Selective inhibition of liver microsomal ifosphamide activation was also effected by the macrolide antibiotic triacetyloleandomycin, an inhibitor of several dexamethasone-inducible 3A P450s. These studies establish that a dexamethasone-inducible family 3A P450 can make an important contribution to rat liver microsomal ifosphamide activation, and suggest that dexamethasone pretreatment might provide a useful approach for modulation of ifosphamide metabolism in order to improve its therapeutic efficacy in cancer patients. 相似文献
38.
The GM2 activator protein is a small monomeric protein containing a single site for Asn-linked glycosylation. Its only proven in vivo function is to act as a substrate specific cofactor for the hydrolysis of GM2 ganglioside by lysosomal beta-hexosaminidase A. However, we and others have shown it can act as a general glycolipid transporter at neutral pH in vitro. Any other possible in vivo functions would require that some of the newly synthesized activator molecules not be targeted to the lysosome. The lysosomal targeting mechanism for the activator has not been conclusively identified. While earlier reports suggested that it is likely through the mannose-6-phosphate receptor, another more recent report demonstrated that deficient human cells could recapture nonglycosylated, bacterially produced activator, suggesting its use of an alternate targeting pathway. Here, we demonstrate that the mannose-6-phosphate pathway is likely the major intracellular, biosynthetic route to the lysosome, as well as a high affinity recapture pathway for the endocytosis of activator protein from extracellular fluids. Additionally, we show that there exists a second lower affinity recapture pathway that requires its native protein structure, is carbohydrate independent, and likely does not involve its ability to bind glycosphingolipids in the plasma membrane. Finally, we document that the pool of newly synthesized precursor activator protein contains a majority of molecules with a complex-type oligosaccharide, which cannot contain a functional mannose-6-phosphate targeting signal. These molecules makeup the secreted forms of the protein in normal human fibroblasts. 相似文献
39.
40.
There is little information on the possible value of screening children who are liable to haemoglobinopathies as part of pre-operative assessment for dental treatment under general anaesthesia. The present retrospective investigation examined, first, the number of patients having low haemoglobin levels among 1000 patients who had undergone haematological investigation prior to general anaesthesia in a dental outpatient unit, and, secondly, the subsequent clinical management of these patients. Haemoglobin levels of 10.0 g/dl or less were found in 31 children: 13 Asian, 7 Afro-Caribbean, 5 Mediterranean, 3 Arabic, 1 white Caucasian and 2 Oriental children. In addition, 17 patients had sickle-cell trait and 2 had beta-thalassaemia trait, but there was no relationship between the presence of haemoglobinopathy and low levels of haemoglobin. The planned general anaesthesia was undertaken for 22 of the 31 children who had low levels of haemoglobin and for the 19 children with haemoglobinopathy. Only 6 children ultimately did not undergo general anaesthesia, all failing to return. It is concluded that pre-anaesthetic haematological assessment of children needing minor dental surgery is rarely of any significant clinical value. 相似文献